Stryker Unveils Hoffmann LRF Hexapod with Pre and Post-Operative Planning Tool for Deformity Correction & Limb Reconstruction Procedures

MAHWAH, N.J., June 29, 2017 – Stryker’s Foot and Ankle business unit today announced the upcoming launch of its new Hoffmann LRF Hexapod hardware and online application, featuring an advanced measurement tool that uses a mathematical algorithm to calculate solutions to correct the deformity. Hoffmann LRF Hexapod is being demonstrated during the American Orthopaedic Foot & Ankle Society (AOFAS) annual meeting from July 12-14 in Seattle.

“Stryker’s Hoffmann LRF Hexapod and its innovative software is a step forward for surgeons and patients involved with complex deformity correction and limb reconstruction procedures. The product is the first-of-its-kind, offering top, as opposed to side, actuating struts, making it easier for patients to reach and manage the hardware,” said John Sontich, MD, Chief of Orthopaedic Trauma at University Hospitals Cleveland Medical Center and past president of the Limb Lengthening and Reconstruction Society. “I am looking forward to using these new technologies to help enhance the patient experience from the first consultation to the end of someone’s treatment.”

Unlike traditional pre-planning, surgeons can upload a patient’s x-rays into the software, which then calculates a treatment solution based on manual inputs by the surgeon, creating a patient-specific plan for strut adjustments. The Hoffmann LRF Hexapod hardware features the core components of Hoffmann LRF with additional flexibility of strut offsetting, allowing the user to relocate the struts to a more optimal position.

Based on the simplicity and reliability of the original Hoffmann Fixator, the versatile Hoffmann LRF product line is designed to match today’s biological repair and reconstruction methods.

“Our team is excited to showcase the benefits of the Hoffmann LRF platform and its intuitive software at AOFAS,” said Tom Popeck, Vice President and General Manager of Stryker’s Foot and Ankle business unit. “We believe this modern deformity correction platform helps streamline the surgical planning process and demonstrates our dedication to moving technology forward with our surgeons and patients best interest in mind.”

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.